A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors

Clinical trial NCT06403735 · RECRUITING

Trial details

NCT number: NCT06403735
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Colorectal Cancer Pancreatic Cancer Solid Tumor

Start date: 2024-04-25
Primary completion: 2026-05-31
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.